ImpediMed announces a successful $15.2 million Capital Raise
Filed with ASX · · 6 pages · English
Watch Impedimed's latest callImpedimed (ASX:IPD) Q1 2027 Earnings Call · Replay · Oct 29Read the transcript of Impedimed (ASX:IPD) Q1 2027 Earnings CallIn the deck
Earlier from Impedimed
- Quarterly Activities Report and Appendix 4C - Mar-2026 Qtr
- ImpediMed Appoints Erik Anderson as Chief Executive Officer
- Appointment of CEO/Managing Director
- FY26 Half Year Financial Results
- Appendix 4D and Interim Financial Report
Later from Impedimed
- Equity Raising Investor Presentation
- CEO Business Update
- Oversubscribed Share Purchase Plan Successfully Completed
- Investor Presentation
- Quarterly Activities Report and Appendix 4C - Jun-2026 Qtr
Follow Impedimed into a list and get an email when it puts out news.
Follow Impedimed